The forecast for blood and blood-forming organs medicine sales in Canada shows steady growth from 2024 to 2028. Sales are projected to increase from $37 in 2024 to $42.3 in 2028 per capita in PPP terms. Comparing these values with actual 2023 sales (not provided), the year-on-year growth rates highlight consistent market expansion, with an average Compound Annual Growth Rate (CAGR) over five years indicating a robust upward trend.

Future trends to watch for include:

Innovations in personalized medicine and biotechnology potentially driving market demand.
Healthcare policy changes, which may impact market dynamics and pricing.
Economic factors, including currency fluctuations and purchasing power adjustments.